Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 4/20 | 1.00 |
| ▸ | DPP4 | P27487 | 1/20 | 1.00 |
| ▸ | APP | P05067 | 11/20 | 0.78 |
| ▸ | MAOB | P27338 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
| ▸ | CA12 | O43570 | 1/20 | 0.69 |
| ▸ | CA1 | P00915 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
| ▸ | CA7 | P43166 | 1/20 | 0.69 |
| ▸ | CA9 | Q16790 | 1/20 | 0.69 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.69 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.65 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.65 |
| ▸ | IAPP | P10997 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Caffeate SCHEMBL782033 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL31059266 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL30602576 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL22196845 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL782032 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL28088236 | 0.97 | TTR (0.94) | TTRDPP4APPMAOBCYP3A4 | |
| SCHEMBL4262080 | 0.97 | TTR (0.94) | TTRDPP4APPMAOBCYP3A4 | |
| SCHEMBL4262076 | 0.97 | TTR (0.94) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL28516367 | 0.95 | TTR (0.91) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL27648151 | 0.95 | TTR (0.91) | TTRDPP4APPMAOBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680027-A1 | A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE | Biocompatibility Innovation Srl (IT) | 2026-01-21 | — | — | EP | claimed |
| WO-2024189407-A1 | A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE | Biocompatibility Innovation S.r.l. (IT) | 2024-09-19 | — | — | WO | claimed |
| CN-116942832-A | Novel anti-infective strategy for combined infection of influenza virus and staphylococcus aureus | 归属疗法有限公司 | 2023-10-27 | — | — | CN | claimed |
| EP-4680027-A1 | A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE | Biocompatibility Innovation Srl (IT) | 2026-01-21 | — | — | EP | disclosed |
| CN-118956378-A | Method for constructing fluorescent probe based on dynamic supermolecule hydrogen bond network and application thereof | 中国科学技术大学 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024189407-A1 | A METHOD FOR IMPARTING ANTIMICROBIAL PROPERTIES TO A SYNTHETIC SUBSTRATE | Biocompatibility Innovation S.r.l. (IT) | 2024-09-19 | — | — | WO | disclosed |
| CN-116942832-A | Novel anti-infective strategy for combined infection of influenza virus and staphylococcus aureus | 归属疗法有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-115869414-A | Composition for increasing water solubility and application | 杭州唯铂莱生物科技有限公司 | 2023-03-31 | — | — | CN | disclosed |